World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 99 8501 7988 483 462 1064 42068

Christoph Bode publications per year

The chart shows the history of publications by Christoph Bode between 1977 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christoph Bode published across 49 years, from 1977 to 2025, averaging 24.3 papers a year. Output peaked at 99 publications in 2021. 18 of the 1,189 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1977 to 2025. Vertical axis: number of publications, 0 to 99. Peak 99 publications in 2021. 1977: 1 publication 1978: 0 publications 1979: 1 publication 1980: 2 publications 1981: 2 publications 1982: 1 publication 1983: 6 publications 1984: 0 publications 1985: 1 publication 1986: 1 publication 1987: 5 publications 1988: 11 publications 1989: 7 publications 1990: 5 publications 1991: 5 publications 1992: 12 publications 1993: 5 publications 1994: 9 publications 1995: 7 publications 1996: 9 publications 1997: 8 publications 1998: 14 publications 1999: 11 publications 2000: 9 publications 2001: 19 publications 2002: 18 publications 2003: 31 publications 2004: 23 publications 2005: 21 publications 2006: 32 publications 2007: 40 publications 2008: 47 publications 2009: 44 publications 2010: 48 publications 2011: 61 publications 2012: 50 publications 2013: 54 publications 2014: 47 publications 2015: 56 publications 2016: 65 publications 2017: 76 publications 2018: 59 publications 2019: 72 publications 2020: 63 publications 2021: 99 publications 2022: 8 publications 2023: 6 publications 2024: 10 publications 2025: 8 publications
1977 2025

1,189 publications in total across all disciplines

View publications per year as a table
Christoph Bode: publications per year, 1977 to 2025
Year Publications
1977 1
1978 0
1979 1
1980 2
1981 2
1982 1
1983 6
1984 0
1985 1
1986 1
1987 5
1988 11
1989 7
1990 5
1991 5
1992 12
1993 5
1994 9
1995 7
1996 9
1997 8
1998 14
1999 11
2000 9
2001 19
2002 18
2003 31
2004 23
2005 21
2006 32
2007 40
2008 47
2009 44
2010 48
2011 61
2012 50
2013 54
2014 47
2015 56
2016 65
2017 76
2018 59
2019 72
2020 63
2021 99
2022 8
2023 6
2024 10
2025 8
Total 1,189
Download as CSV

Christoph Bode publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christoph Bode sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,061–1,080 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,064 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77 1,064
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Christoph Bode D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Bode sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668 99
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Christoph Bode is affiliated with the University of Freiburg in Germany and conducts research primarily in the field of Business, Management and Accounting, with a particular focus on Strategy and Management, Management Information Systems, and Information Systems. Their work also spans Industrial and Manufacturing Engineering and Accounting.

Their research covers various main topics including Outsourcing and Supply Chain Management, Supply Chain Resilience and Risk Management, Quality and Supply Management, Software Engineering Techniques and Practices, Sustainable Supply Chain Management, Risk Management in Financial Firms, and Manufacturing Process and Optimization.

Among the frequent coauthors collaborating with Christoph Bode are Jan Martin Spreitzenbarth, Heiner Stuckenschmidt, Davide Burkhart, Ruth Schültken, and Sandro Wartzack.

They have published multiple research papers in notable venues. Recent papers include:

  • "Artificial intelligence and machine learning in purchasing and supply management: A mixed-methods review of the state-of-the-art in literature and practice" (2024, Journal of Purchasing and Supply Management)
  • "On supplier resilience: How supplier performance, disruption frequency, and disruption duration are interrelated" (2024, Journal of Purchasing and Supply Management)
  • "Supply disruptions and protection motivation: Why some managers act proactively (and others don't)" (2021, Journal of Business Logistics)
  • "Financially distressed suppliers: exit, neglect, voice or loyalty?" (2021, The International Journal of Logistics Management)
  • "The State of Artificial Intelligence: Procurement versus Sales and Marketing" (2022, SSRN Electronic Journal)

Christoph Bode's publication record also includes contributions to book series, notably three editions of Supply Management Research published by Advances in Supply Management in 2020, 2021, and 2022.

Their frequent publication venues include:

  • Academy of Management Proceedings
  • European Romantic Review
  • Journal of Purchasing and Supply Management
  • SSRN Electronic Journal
  • Procedia CIRP

Best Publications

  • Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

    Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

  • Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

    C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin

  • AN EMPIRICAL EXAMINATION OF SUPPLY CHAIN PERFORMANCE ALONG SEVERAL DIMENSIONS OF RISK

    Stephan M. Wagner;Christoph Bode

  • An empirical investigation into supply chain vulnerability

    Stephan M. Wagner;Christoph Bode

  • Understanding Responses to Supply Chain Disruptions: Insights from Information Processing and Resource Dependence Perspectives

    Christoph Bode;Stephan M. Wagner;Kenneth J. Petersen;Lisa M. Ellram

  • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

    EJ Topol;AM Lincoff;RM Califf;EM Ohman

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Chronic variable stress activates hematopoietic stem cells

    Timo Heidt;Hendrik B Sager;Gabriel Courties;Partha Dutta

  • Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction

    Christian Spaulding;Patrick Henry;Emmanuel Teiger;Kevin Beatt

  • Structural drivers of upstream supply chain complexity and the frequency of supply chain disruptions

    Christoph Bode;Stephan M. Wagner

  • Early versus delayed, provisional eptifibatide in acute coronary syndromes.

    Robert P. Giugliano;Jennifer A. White;Christoph Bode;Paul W. Armstrong

  • A COMPARISON OF HIRUDIN WITH HEPARIN IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY

    Patrick W. Serruys;Jean-Paul R. Herrman;Rudiger Simon;Wolfgang Rutsch

  • Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest

    Bernd W. Böttiger;Hans-Richard Arntz;Douglas A. Chamberlain;Erich Bluhmki

  • Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.

    Gilles Montalescot;Harvey D. White;Richard Gallo;Marc Cohen

  • Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction

    Marc S. Sabatine;David A. Morrow;Luke J. Higgins;Catherine MacGillivray

  • Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.

    Bernd W Böttiger;Christoph Bode;Christoph Bode;Sabine Kern;André Gries

  • The Effects of Serotonin in Immune Cells

    Nadine Herr;Christoph Bode;Daniel Duerschmied

  • More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction

    Richard W. Smalling;Christoph Bode;John Kalbfleisch;Semi Sen

  • Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice

    Daniel Duerschmied;Georgette L. Suidan;Georgette L. Suidan;Melanie Demers;Melanie Demers;Nadine Herr

  • Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL) Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size

    E. Regar;P.W. Serruys;C. Bode;C. Holubarsch

Frequent Co-Authors

Karlheinz Peter
Karlheinz Peter Baker IDI Heart and Diabetes Institute
Friedhelm Beyersdorf
Friedhelm Beyersdorf University of Freiburg
Manfred Olschewski
Manfred Olschewski University of Freiburg
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Cam Patterson
Cam Patterson University of Arkansas for Medical Sciences
Peter Libby
Peter Libby Brigham and Women's Hospital
Marc Cohen
Marc Cohen RWJBarnabas Health
Freek W.A. Verheugt
Freek W.A. Verheugt University Medical Centre Mannheim
Jan J. Piek
Jan J. Piek University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring pathways into the healthcare field doesn’t always mean going to medical school. Many students are opting for flexible online degrees and alternative career tracks that allow them to enter the workforce more quickly. For example, direct entry msn online programs are a great choice for individuals with a non-nursing background who want to become advanced practice nurses without completing a traditional BSN.

Other prospective nurses may look into more accessible options, such as online adn programs, which can provide a solid, quicker foundation in nursing and may have less competitive entry requirements. For those interested in supporting healthcare through administration, medical billing and coding schools that accept fafsa offer accessible routes, often with financial aid, leading directly to in-demand healthcare positions.

Flexibility is key, with some nursing schools removing common barriers to entry like standardized tests. Choosing a nursing school that does not require teas test lets students start their nursing journey without the stress of extra exams, further opening the doors to a healthcare career. Exploring these diverse pathways allows students to find a program that fits their academic background, learning style, and career goals.

Best Scientists Citing Christoph Bode

Trending Scientists

Recently Published Articles